1. Figure 2 Examples of histopathological validation
of patients with CUP with an EPICUP-predicted tissue of origin
Figure 2 | Examples of histopathological validation of patients with CUP with an EPICUP-predicted tissue of origin. a | CUP predicted by EPICUP to be a sarcoma: histopathological validation of the EPICUP-based diagnosis using a tumour sample after autopsy, using haematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) for vimentin, a specific marker for sarcoma, and the non-sarcoma marker S100 (negative). b | CUP predicted by EPICUP to be breast cancer. Diagnosis was confirmed by H&E staining and IHC for cytokeratins CK-7 (positive) and CK-20 (negative), and the specific breast marker mammaglobin-A (positive). c | CUP predicted to be a colon carcinoma by EPICUP, and validated using H&E staining and IHC for CK-7 (negative), CK20 (positive), and the specific colon marker homeobox protein CDX-2 (positive).
Moran, S. et al. (2017) Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary
Nat. Rev. Clin. Oncol. doi: /nrclinonc